Italia markets open in 3 hours 40 minutes

ILMN Dec 2024 240.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,70000,0000 (0,00%)
In data: 09:30AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente2,7000
Aperto2,7000
Denaro0,0000
Lettera0,0000
Prezzo d'esercizio240,00
Scadenza2024-12-20
Min-Max giorno2,7000 - 2,7000
Contratto - Min-MaxN/D
Volume1
Open Interest22
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera